Moreover, BCAA supplementation reduced the risk of HCC in obese patients with chronic viral liver disease [46], demonstrating the clinical significance of lowering insulin levels and attenuating insulin resistance in the prevention of liver carcinogenesis in obese and diabetic patients. This evidence concerns the gene INS and hepatocellular carcinoma.